Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study
- PMID: 16928344
- DOI: 10.1007/s11910-996-0015-x
Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study
Similar articles
-
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.Eur J Neurol. 2006 Sep;13(9):981-5. doi: 10.1111/j.1468-1331.2006.01409.x. Eur J Neurol. 2006. PMID: 16930364 Clinical Trial.
-
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.J Am Geriatr Soc. 2001 Dec;49(12):1590-9. J Am Geriatr Soc. 2001. PMID: 11843990 Clinical Trial.
-
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.Arch Intern Med. 1998 May 11;158(9):1021-31. doi: 10.1001/archinte.158.9.1021. Arch Intern Med. 1998. PMID: 9588436 Clinical Trial.
-
Donepezil for Alzheimer's disease?Drug Ther Bull. 1997 Oct;35(10):75-6. Drug Ther Bull. 1997. PMID: 9489056 Review. No abstract available.
-
Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. doi: 10.1159/000051201. Dement Geriatr Cogn Disord. 1998. PMID: 9853200 Review.
Cited by
-
Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3. Cochrane Database Syst Rev. 2018. PMID: 29923184 Free PMC article.
-
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review.Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10. Mol Neurobiol. 2025. PMID: 39254911 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical